Michele Wilson, MSPH

Director of Health Economics
RTI Health Solutions
Research Triangle Park, NC

Authored Items

Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn’s Disease

Michele Wilson, MSPH, Aaron Lucas, PhD, MPH;, Ann Cameron, MA, PhD;, Michelle Luo, PhD

July 2018 Vol 11, No 5 in Business, Original Research

Last modified: July 20, 2018

• 
• 
• 

• 
• 
• 

• 
•